Kemin to Launch Lutein Granule for Tablet Market

07/04/06 Kemin Health Europe has announced plans to launch the new “revolutionary” FloraGLO“ Lutein 10% VG Tabgrade granules during the upcoming Vitafoods trade show in Geneva, Switzerland in May.

FloraGLO Lutein 10% VG Tabgrade granule is the first high payload original-free lutein beadlet totally suitable for the tablet market, bringing performance to the highest level and maintaining the characteristics that have made Kemin Health the worldwide lutein leader. In an effort to address the increasing demands on the fast-growing tablet-grade market, the new FloraGLO Lutein 10% VG Tabgrade is the premium solution for the industry, delivering excellent stability both upon and after compression in stand-alone lutein products and multi-ingredient formulations. Additionally, by having a 10% FloraGLO Lutein inclusion level, manufacturers can rely on a higher payload, so important in today’s cost leadership economy.

Using all-vegetarian ingredients, Kemin Health Europe is clearly positioned to serve the European market not only to the ever more demanding customers but also to the information-savvy consumers. Moreover, an emphasis has been put to assure that the product meets all regulatory and quality requisites in the European market. Non-GMO, no preservative, allergen free and Kosher are just some of the offered attributes aligned with what the consumer wants.

Research has suggested a minimum of 6-10 mg per day of lutein is necessary to realize lutein’s health benefits. One such benefit is lutein’s role in eye health, specifically its role in reducing the risk of Age Related Macular Degeneration (AMD). AMD occurs when the fragile center of the retina–the macula–deteriorates from a lifetime of slow but steady damage. The macula is a small area of the retina responsible for central vision, and high visual acuity. Poor macular health can cause oxidative stress within the retina, leading to a loss of central vision.